A basic classification and a comprehensive examination of pediatric myeloproliferative syndromes

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 4, 2005, Pages 192-196

  Gassas, Adam ^a   Doyle, John J ^a   Weitzman, Sheila ^a   Freedman, Melvin H ^a   Hitzler, Johann K ^a   Sharathkumar, Anjali ^a   Dror, Yigal ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chronic myelogenous leukemia; Down syndrome classification; Juvenile myelomonocytic leukemia; Myeloproliferative syndromes

Indexed keywords

ANAGRELIDE;

ADOLESCENT; AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; CELL LINEAGE; CELL PROLIFERATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOGENETICS; DISEASE CLASSIFICATION; DOWN SYNDROME; ERYTHROCYTOSIS; FAMILIAL ERYTHROCYTOSIS; FAMILIAL THROMBOCYTOSIS; FEMALE; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFANT; INFECTION; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MAST CELL; MONOCYTIC LEUKEMIA; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NEWBORN; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; STEM CELL; SURVIVAL; SYSTEMIC MASTOCYTOSIS; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME;

ADOLESCENT; BONE MARROW; CELL LINEAGE; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MYELOPROLIFERATIVE DISORDERS; PROGNOSIS; SURVIVAL RATE;

EID: 18044381318     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000159934.35079.b5     Document Type: Conference Paper

References (32)

1. Bennett JM, Catovsky D, Daniel MT. Proposals for classification of myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
2. Harris NL, Jaffe ES, Diebold J. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House. J Clin Oncol. 1999;17:3835-3849.
3. Mandel K, Dror Y, Poon A, et al. A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC System. J Pediatr Hematol Oncol. 2002;24:596-605.
4. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17:277-282.
5. Homans AC, Verissimo AM, Vlacha V. Transient abnormal myelopoiesis of infancy associated with triosomy 21. Am J Pediatr Hematol Oncol. 1993;15:392-399.
6. Smith FO, Woods WG. Myeloproliferative and myelodysplastic disorders. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins, 2002:615-636.
7. Robert IAG, Dokal IS. Adult-type chronic myeloid leukemia. In: Lilleyman J, Hann I, Blanchette V, eds. Pediatric Hematology. London: Churchill Livingstone, 1999:403-416.
8. Niemeyer CM, Fenu S, Hasle H, et al. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood. 1998;91:365-367.
9. Murphy S. Thrombocytosis and thrombocythaemia. Clin Haematol. 1983;12:89-106.
10. Pearson TC, Messinezy M. The diagnostic criteria of polycythemia rubra vera. Leuk Lymphoma. 1996;22:87-93.
11. Thiele J, Kvasnicka HM, Zankovich R, et al. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol. 2001;80:160-165.
12. Michiels JJ, Thiele J. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia). Int J Hematol. 2002;76:133-145.
13. Altura RA, Head DR, Wang WC. Long-term survival of infants with idiopathic myelofibrosis. Br J Haematol. 2000;109:459-462.
14. Thiele J, Kvasnicka HM. Chronic myeloproliferative disorders: the new WHO classification. Pathologe. 2001;22:429-443.
15. Bunin N, Saunders F, Leahey A, et al. Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol. 1999;21:479-485.
16. Sharathkumar A, Thornley I, Saunders EF, et al. Allogeneic bone marrow transplantation in children with chronic myelogenous leukemia. J Pediatr Hematol Oncol. 2002;24:215-219.
17. Dror Y, Leaker M, Caruana G, et al. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis. Br J Haematol. 2000;108:729-736.
18. Lau S, Ramsay N, Smith CD, et al. Spontaneous resolution of severe childhood myelofibrosis. J Pediatr. 1981;98:585-588.
19. Cetingul N, Yener E, Oztop S, et al. Agnogenic myeloid metaplasia in childhood: a report of two cases and efficiency of intravenous high dose methylprednisolone treatment. Acta Paediatr Jpn. 1994;36:697-700.
20. Sekhar M, Prentice H, Popat U, et al. Idiopathic myelofibrosis in children. Br J Haematol. 1996;93:394-397.
21. Kondo T, Okabe M, Sanada M, et al. Familial essential thrombocythemia with one-base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood. 1998;92:1091-1096.
22. Kikuchi M, Tayama T, Haykawa H, et al. Familial thrombocytosis. Br J Haematol. 1995;89:900-902.
23. Manglani MV, De Graff CG, Dukes PP, et al. Congenital erythrocytosis with elevated erythropoietin level: an incorrectly "erythrostat"? J Pediatr Hematol Oncol. 1998;20:560-562.
24. Arcasoy MO, Degar BA, Harris KW, et al. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood. 1997;89:4628-4635.
25. Dror Y, Zipursky A, Blanchette VS. Essential thrombocythemia in children. J Pediatr Hematol Oncol. 1999;21:356-363.
26. Dameshek W. Some speculations on the myeloproliferative syndromes. Blood. 1951;6:372.
27. Emanuel PD. Myelodysplasia and myeloproliferative disorders in childhood: an update. Br J Haematol 1999;105:852-863.
28. Nosslinger T, Reisner R, Koller E, et al. Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution. Blood. 2001;98:2935-2941.
29. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;13:193-207.
30. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999;93:459-466.
31. Hasle H, Arico M, Basso G, et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia. 1999;13:376-385.
32. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.